Literature DB >> 32669495

Colonic Amyloidosis Concomitant with Systemic Lupus Erythematosus.

Kozo Ikuta1, Saori Hatachi2, Takahiro Fujimori3, Seiji Shio1.   

Abstract

Entities:  

Keywords:  amyloidosis; systemic lupus erythematosus

Year:  2020        PMID: 32669495      PMCID: PMC7691021          DOI: 10.2169/internalmedicine.5109-20

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


× No keyword cloud information.
A 43-year-old woman with a 20-year history of systemic lupus erythematosus (SLE) complained of lower abdominal pain and a high fever. We and her previous physicians had controlled the disease activity of SLE well using prednisolone, tacrolimus, hydroxychloroquine and mycophenolate mofetil for a number of years. Abdominal ultrasonography and computed tomography (CT) showed swelling of the ascending colonic wall (Picture 1, 2). Colonoscopy showed mucosal swelling and small red spots in the ascending colon (Picture 3). Congo red staining using the biopsy specimens from the swollen mucosa was positive for amyloid deposition, and green birefringence was observed under polarized light (Picture 4). Given that Congo red staining with prior potassium permanganate incubation was negative, we diagnosed her with amyloid A (AA) amyloidosis of the ascending colon. AA amyloidosis is sometimes associated with rheumatoid arthritis but rarely with SLE (1,2). In this case, the long history of SLE may have contributed to the development of AA amyloidosis.
Picture 1.
Picture 2.
Picture 3.
Picture 4.
The authors state that they have no Conflict of Interest (COI).
  2 in total

1.  Amyloid A amyloidosis and systemic lupus erythematosus.

Authors:  Nursen Düzgün
Journal:  Expert Rev Clin Immunol       Date:  2007-09       Impact factor: 4.473

2.  Proliferative lupus nephritis in a patient with systemic lupus erythematosus and longstanding secondary amyloid nephropathy.

Authors:  Jose A Gómez-Puerta; Ricard Cervera; Concepción Moll; Manel Solé; Antonio Collado; Raimon Sanmartí
Journal:  Clin Rheumatol       Date:  2008-10-22       Impact factor: 2.980

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.